• ⌘ + K
  • Home
  • 0
    Inbox
Explore
  • Browse All
  • Health
  • FedCiv
  • Defense
  • Events
Work
  • Teaming Hub
  • Watchlists
  • Bookmarks
  • Notes
Research
  • Grants
    • Contracts
    • Vehicles
    • OTAs
    • OTIDVs
  • Agencies
  • NAICS
  • PSC
  • DOGE Tracker

Federal Contract Vehicles

47vehicles

Track IDIQs, BPAs, and ordering channels, watch vehicle activity for new transactions, and identify where future task-order pursuits may flow.

Awardee
is
FYZXNHSQTMG8
Reference IDV
Awardee
Description
Vehicle Type
Ceiling
Awarding Agency
Funding Agency
Set Aside
NAICS
PSC
Award Date
Start Date
Last Date to Order
36E79726D0021
EXELAN PHARMACEUTICALS INC—IDC$4,242,730VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMar 5, 2026Jun 15, 2026Jun 14, 2027
36E79726D0020
EXELAN PHARMACEUTICALS INCNEW AWARD FOR METOPROLOL TARTRATE TABLETS WITH EXELAN PHARMACEUTICALS, INC. ORDERING PERIOD IS MAY 8, 2026 TO MAY 7, 2027 WITH FOUR ONE-YEAR OPTIONS.IDC$13,952,068VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSFeb 4, 2026May 8, 2026—
36E79726D0017
EXELAN PHARMACEUTICALS INCNEW AWARD FOR BUMETANIDE TABLETS WITH EXELAN PHARMACEUTICALS, INC.. PERIOD OF PERFORMANCE IS MAY 30, 2026, TO MAY 29, 2027, WITH FOUR ONE-YEAR OPTIONS.IDC$5,595,064VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 16, 2026May 30, 2026—
36C26226A0006
EXELAN PHARMACEUTICALS INCLENALIDOMIDE VISN 22 BPABPA$21,167,021VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 13, 2026Jan 15, 2026Jan 14, 2027
36E79726D0003
EXELAN PHARMACEUTICALS INC—IDC$29,942,818VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSOct 9, 2025Feb 1, 2026—
36E79725D0036
EXELAN PHARMACEUTICALS INCNEW AWARD FOR TAMSULOSIN HCL 0.4MG CAPSULES WITH EXELAN PHARMACEUTICALS INC. ORDERING PERIOD IS SEPT. 7, 2025 TO SEPT. 6, 2026 WITH FOUR ONE-YEAR OPTIONSIDC$88,222,847VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJul 8, 2025Sep 7, 2025Sep 6, 2026
36E79725D0047
EXELAN PHARMACEUTICALS INC—IDC$63,068,832VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJul 2, 2025Sep 3, 2025—
36E79725D0018
EXELAN PHARMACEUTICALS INC—IDC$7,656,787VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSApr 3, 2025Jun 3, 2025Jun 2, 2027
36E79725D0002
EXELAN PHARMACEUTICALS INC—IDC$4,792,297VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSOct 21, 2024Dec 20, 2024—
SPE2D224D0007
EXELAN PHARMACEUTICALS INC4610113118!PHARM MANUF/DISTR DIV - FSAIDC$29,031,545DEFENSE LOGISTICS AGENCYDEFENSE LOGISTICS AGENCY—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSAug 13, 2024Aug 13, 2024—
SPE2D224D0003
EXELAN PHARMACEUTICALS INC4610108341!PHARM MANUF/DISTR DIV - FSAIDC$6,984,110DEFENSE LOGISTICS AGENCYDEFENSE LOGISTICS AGENCY—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSFeb 12, 2024Feb 12, 2024—
36E79724D0014
EXELAN PHARMACEUTICALS INCNEW AWARD FOR ESCITALOPRAM OXALATE TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS MAR 17, 2024 TO MAR 16, 2025 WITH FOUR ONE-YEAR OPTIONS.IDC$48,442,918VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 17, 2024Mar 17, 2024Mar 16, 2027
36E79724D0012
EXELAN PHARMACEUTICALS INCNEW AWARD FOR OSELTAMIVIR PHOSPHATE CAPSULES AND SUSPENSION WITH EXELAN. PERIOD OF PERFORMANCE 2-22-2024 - 2-21-2025.IDC$10,164,263VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSDec 14, 2023Feb 22, 2024—
SPE2D223D0005
EXELAN PHARMACEUTICALS INC—IDC$28,235,184DEFENSE LOGISTICS AGENCYDEFENSE LOGISTICS AGENCY—325411Medicinal and Botanical Manufacturing6505DRUGS AND BIOLOGICALSFeb 1, 2023Feb 1, 2023Jan 31, 2028
36E79722D0038
EXELAN PHARMACEUTICALS INC—IDC$28,781,200VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 26, 2022Feb 19, 2023—
36E79722D0026
EXELAN PHARMACEUTICALS INC—IDC$10,379,934VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMay 31, 2022Oct 27, 2022—
36E79722D0022
EXELAN PHARMACEUTICALS INC—IDC$15,582,999VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSApr 21, 2022Jun 20, 2022Jun 19, 2025
36E79722D0010
EXELAN PHARMACEUTICALS INC—IDC$12,802,166VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 13, 2022Mar 14, 2022Mar 13, 2027
36E79722D0005
EXELAN PHARMACEUTICALS INCNEW AWARD FOR LISINOPRIL TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS FEB 12, 2022 TO FEB 11, 2023 WITH FOUR ONE-YEAR OPTIONS.IDC$40,480,225VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSDec 14, 2021Feb 12, 2022Feb 11, 2027
SPE2D221D0135
EXELAN PHARMACEUTICALS INC—IDC$24,078,212DEFENSE LOGISTICS AGENCYDEFENSE LOGISTICS AGENCY—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJun 28, 2021Jun 28, 2021—
SPE2D221D0134
EXELAN PHARMACEUTICALS INC4610076615!MANUFACTURE/DISTRIBUTOR BR-PHIDC$5,592,523DEFENSE LOGISTICS AGENCYDEFENSE LOGISTICS AGENCY—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJun 8, 2021Jun 8, 2021—
36E79721D0035
EXELAN PHARMACEUTICALS INCNEW AWARD FOR ZONISAMIDE CAPSULES WITH EXELAN PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS JUNE 15, 2021 TO JUNE 14, 2022 WITH FOUR 0NE-YEAR OPTIONS.IDC$8,974,952VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSApr 16, 2021Jun 15, 2021—
36E79721D0018
EXELAN PHARMACEUTICALS INC—IDC$18,098,362VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 29, 2021Mar 2, 2021Mar 1, 2026
36E79720D0064
EXELAN PHARMACEUTICALS INCNEW AWARD FOR TOPIRAMATE TABLETS WITH EXELAN PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 10/31/2020 TO 10/30/2021 WITH FOUR ONE-YEAR OPTIONS.IDC$32,360,809VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 24, 2020Oct 31, 2020—
36F79720D0227
EXELAN PHARMACEUTICALS INC65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARDFSS$3,077,719,680VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 1, 2020Sep 15, 2020Sep 14, 2026
Page 1 of 2
  • Previous
  • Next